Titan Pharmaceuticals
TTNP
#11004
Rank
โ‚น0.56 B
Marketcap
โ‚น427.30
Share price
-3.76%
Change (1 day)
21.64%
Change (1 year)

EPS for Titan Pharmaceuticals (TTNP)

EPS in 2025 (TTM): -โ‚น369.19

According to Titan Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is -โ‚น406.91. In 2023 the company made an earnings per share (EPS) of -โ‚น686.83 an increase over its 2022 EPS that were of -โ‚น1,408.

EPS history for Titan Pharmaceuticals from 1996 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-โ‚น369.19
2023-โ‚น686.83-51.22%
2022-โ‚น1,408-15.61%
2021-โ‚น1,668-81.37%
2020-โ‚น8,954-77.52%
2019-โ‚น39,838-56.32%
2018-โ‚น91,208-59.51%
2017-โ‚น2,25,284-371.81%
2016โ‚น82,882-144.35%
2015-โ‚น1,86,865300%
2014-โ‚น46,716-121.54%
2013โ‚น2,16,896-151.38%
2012-โ‚น4,22,114-11.54%
2011-โ‚น4,77,172188.89%
2010-โ‚น1,65,175-10%
2009-โ‚น1,83,528
2007-โ‚น7,52,464-2.38%
2006-โ‚น7,70,817-39.13%
2005-โ‚น12,66,342-16.87%
2004-โ‚น15,23,281-22.43%
2003-โ‚น19,63,7484.9%
2002-โ‚น18,71,98461.9%
2001-โ‚น11,56,225-13.7%
2000-โ‚น13,39,75365.01%
1999-โ‚น8,11,936-35.87%
1998-โ‚น12,66,126-1824.71%
1997โ‚น73,411-102.4%
1996-โ‚น30,64,915

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
โ‚น619.15-252.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚น486.62-219.59%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Vanda Pharmaceuticals
VNDA
-โ‚น428.23 5.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
-โ‚น18.54-95.44%๐Ÿ‡บ๐Ÿ‡ธ USA
MediciNova
MNOV
-โ‚น21.32-94.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-โ‚น403.20-0.91%๐Ÿ‡บ๐Ÿ‡ธ USA